IRIS
Grimaldi, Luigi Maria Edoardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.050
SA - Sud America 832
NA - Nord America 682
EU - Europa 186
AF - Africa 60
OC - Oceania 2
Totale 3.812
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 1.076
BR - Brasile 727
US - Stati Uniti d'America 562
CN - Cina 350
VN - Vietnam 233
HK - Hong Kong 188
MX - Messico 89
IT - Italia 48
AR - Argentina 35
BD - Bangladesh 35
GB - Regno Unito 31
ID - Indonesia 28
ZA - Sudafrica 26
FR - Francia 25
IQ - Iraq 25
EC - Ecuador 23
CO - Colombia 21
DE - Germania 21
IN - India 20
UA - Ucraina 17
PK - Pakistan 13
TR - Turchia 13
RU - Federazione Russa 12
SA - Arabia Saudita 12
CA - Canada 11
UZ - Uzbekistan 9
EG - Egitto 7
KE - Kenya 7
NL - Olanda 7
CL - Cile 6
JM - Giamaica 6
MA - Marocco 6
VE - Venezuela 6
NP - Nepal 5
PE - Perù 5
PH - Filippine 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
BN - Brunei Darussalam 3
ES - Italia 3
IE - Irlanda 3
JO - Giordania 3
JP - Giappone 3
OM - Oman 3
AL - Albania 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
ET - Etiopia 2
IR - Iran 2
KZ - Kazakistan 2
MY - Malesia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
ZM - Zambia 2
AM - Armenia 1
AU - Australia 1
BG - Bulgaria 1
BS - Bahamas 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
FI - Finlandia 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HT - Haiti 1
HU - Ungheria 1
IL - Israele 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
LU - Lussemburgo 1
MR - Mauritania 1
NO - Norvegia 1
PA - Panama 1
PF - Polinesia Francese 1
PL - Polonia 1
PS - Palestinian Territory 1
RE - Reunion 1
SE - Svezia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UG - Uganda 1
Totale 3.812
Salva come PNG Salva come JPEG
Città #
Singapore 459
Ashburn 296
Beijing 193
Hong Kong 183
Ho Chi Minh City 89
Mexico City 77
São Paulo 56
Hanoi 43
New York 38
Rio de Janeiro 28
Rome 22
Haiphong 17
Brasília 15
Belo Horizonte 13
Council Bluffs 13
Curitiba 13
Porto Alegre 13
Guarulhos 12
Da Nang 11
Baghdad 10
Campinas 10
Dhaka 10
Dallas 9
Recife 9
Biên Hòa 8
Goiânia 8
Tashkent 8
Hải Dương 7
Nova Iguaçu 7
Quito 7
Santa Clara 7
Secaucus 7
Cape Town 6
Frankfurt am Main 6
Guayaquil 6
Jakarta 6
Johannesburg 6
Nairobi 6
Salvador 6
Bexley 5
Bogotá 5
Caxias do Sul 5
Duque de Caxias 5
Manaus 5
Ourinhos 5
Pasig-bo 5
Ribeirão Preto 5
Santa Maria 5
Boardman 4
Boydton 4
Campina Grande 4
Casablanca 4
Chicago 4
Fortaleza 4
Jeddah 4
Kingston 4
Magé 4
Maricá 4
Mauá 4
Medellín 4
Milan 4
Natal 4
Passo Fundo 4
Santiago de Cali 4
Santo André 4
Shanghai 4
São José dos Campos 4
São Vicente 4
Thái Bình 4
Uberlândia 4
Arapiraca 3
Asunción 3
Atibaia 3
Baku 3
Bento Gonçalves 3
Boa Vista 3
Bragança Paulista 3
Can Tho 3
Carapicuíba 3
Chapecó 3
Contagem 3
Dammam 3
Dubai 3
Duhok 3
Houston 3
Ipatinga 3
Istanbul 3
João Pessoa 3
Juiz de Fora 3
Karachi 3
Lima 3
Limeira 3
Los Angeles 3
Lucknow 3
Lấp Vò 3
Macaé 3
Marília 3
Novo Hamburgo 3
Osasco 3
Quảng Ngãi 3
Totale 1.963
Salva come PNG Salva come JPEG
Nome #
Cytokines and immunity in multiple sclerosis: The dual signal hypothesis 164
Rivastigmine may be helpful for the dementia of Parkinson's disease 27
Absence of IgG, IgA or IgM oligoclonal bands in tears from multiple sclerosis patients 25
18F-Florbetaben PET/CT to Assess Alzheimer's Disease: A new Analysis Method for Regional Amyloid Quantification 23
A novel missense mutation (L219F) in exon 8 of the preselinin 1 gene in an Italian family with presenile familial Alzheimer's disease 23
An Italian programme for COVID-19 infection in multiple sclerosis 22
Multiple Sclerosis Progression and Relapse Activity in Children 21
Multicenter Interventional Phase IV Study for the Assessment of the Effects on Patient's Satisfaction of Peg IFN Beta-1a (Pre-filled Pen) in Subjects With Relapsing–Remitting Multiple Sclerosis Unsatisfied With Other Injectable Subcutaneous Interferons (PLATINUM Study) 20
The italian pharmacovigilance program: An observational study of adverse effects of natalizumab in multiple sclerosis therapy 20
Absence of engraftment of lymphoid organs in hu-PBL SCID mice: a study employing fluorescent in situ hybridization (FISH) for the identification of human cells 19
Improved conditions for the analysis of large variable number of tandemly repeated (VNTR) unit polymorphisms 19
The pervasiveness of interleukin-1 in Alzheimer pathogenesis: A role for specific polymorphisms in disease risk 19
Light chain composition of CSF and sera oligoclonal IgG bands in asymptomatic HIV seropositive (AHS) and AIDS patients with central nervous system (CNS) involvement 19
Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy 19
Autoantibodies to glutamic acid decarboxylase (GAD) detected by an immuno-trapping enzyme activity assay: Relation to insulin-dependent diabetes mellitus and islet cell antibodies 19
The role of IL-1 gene cluster in longevity: A study in Italian population 19
Association of early onset Alzheimer's disease with an interleukin-1 α polymorphism 18
Radiomics Analysis of Brain [18 F]FDG PET/CT to Predict Alzheimer’s Disease in Patients with Amyloid PET Positivity: A Preliminary Report on the Application of SPM Cortical Segmentation, Pyradiomics and Machine-Learning Analysis 18
Variation of oligoclonal IgG banding pattern during lumbar CSF removal from MS patients 18
Longitudinal changes in social functioning in mildly disabled patients with relapsing–remitting multiple sclerosis receiving subcutaneous interferon beta-1a: results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study (II) 18
Natalizumab in pediatric multiple sclerosis: Results of a cohort of 55 cases 18
The molecular anatomy of human Hps60 and its similarity with that of bacterial orthologs and acetylcholine receptor reveal a potential patogenetic role of anti-chaperonin immunity in myasthenia gravis 18
Clinical effectiveness of different natalizumab interval dosing schedules in a large Italian population of patients with multiple sclerosis 18
Association study of two APOE polymorphisms in Italian MS patients 18
A whole genome screen for linkage disequilibrium in multiple sclerosis performed in a continental Italian population 18
Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial 18
The pharmacovigilance program on natalizumab in Italy: 2 years of experience 17
Failure to transfer multiple sclerosis into SCID mice by intraperitoneal injection of PBLs from MS patients 17
Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1α 17
Induction of IL-1 receptor antagonist by interferon beta: Implication for the treatment of multiple sclerosis 17
Intravenous or subcutaneous natalizumab in patients with relapsing–remitting multiple sclerosis: investigation on efficiency and savings—the EASIER study 17
Absence of human herpesvirus 6 and 7 from spinal fluid and serum of multiple sclerosis patients 17
Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study 17
Absence of oligoclonally restricted immunoglobulins in tears from multiple sclerosis patients 17
A pilot study on the use of interferon beta-1a in early Alzheimer's disease subjects 16
A polymorphism in the interleukin-1α gene influences the clinical features of migraine 16
Discontinuous distribution of IgG oligoclonal bands in cerebrospinal fluid from multiple sclerosis patients 16
A γ-interferon-activated Ca2+ influx in T-lymphocytes from multiple sclerosis patients influences immune activation during disease exacerbation 16
Registers as central real world data source: the experience of the Italian Multiple Sclerosis and Related Disorders Register 16
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register 16
Apolipoprotein E and α-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease 16
γ-interferon activates a new Ca2+ influx in T-lymphocytes from multiple sclerosis patients 16
A randomized study of natalizumab dosing regimens for relapsing–remitting multiple sclerosis 16
The Italian multiple sclerosis register 16
Tumor necrosis factor in serum and cerebrospinal fluid of patients with multiple sclerosis 16
A new promoter polymorphism in the alpha-1-antichymotrypsin gene is a disease modifier of Alzheimer's disease 16
γ Interferon activates a previously undescribed Ca2+ influx in T lymphocytes from patients with multiple sclerosis 16
Stiff-man syndrome in a patient with Hodgkin's disease. An unusual paraneoplastic syndrome 16
Italian Neurological Society guidelines for the diagnosis of dementia: Revision l 16
Cholesterol abnormalities in a cohort of Sicilian patients with multiple sclerosis 16
Relevance of an intronic polymorphism in myasthenia gravis: a preliminary study 16
Central nervous system delivery of interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination 16
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study 16
Vettori erpetici per la terapia genica di patologie del sistema nervoso centrale 15
Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratification 15
Reply 15
Kappa light chain predominance in serum and cerebrospinal fluid from human immunodeficiency virus type 1 (HIV-1)-infected patients 15
Interferon-β treatment does not induce a “protective” shift towards T helper 2 cells in multiple sclerosis patients 15
Soluble interleukin-1 receptor antagonist intron 2 polymorphism is associated with occurrence and clinical disability in patients with multiple sclerosis 15
Absence of central nervous system pathology in severe combined immunodeficiency mice intraperitoneally injected with peripheral blood lymphocytes from multiple sclerosis patients 15
T cell activation in experimental allergic encephalomyelitis is associated with increase in size of the ER-associated but not of the IP3-sensitive Ca2+ pool 15
Natalizumab in the pediatric MS population: Results of the Italian registry 15
Identification of peptides binding to IgG in the CSF of multiple sclerosis patients 15
SOLUBLE INTERLEUKIN-1 RECEPTOR ANTAGONIST INTRON 2 POLYMORPHISM: FUNCTIONAL ROLE AND RELEVANCE IN MULTIPLE SCLEROSIS 15
The human-myasthenic mouse chimera: a new approach to study myasthenia gravis (MG) 15
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension 15
Anti-inflammatory and cognitive effects of interferon-?1a (IFN?1a) in a rat model of Alzheimer's disease 15
Una chimera uomo/topo per lo studio delle malattie neurologiche 15
Hu-SCID mice 15
Reply 15
Efficacy and tolerability of natalizumab in relapsing-remitting multiple sclerosis patients: a post-marketing observational study 15
Tumor necrosis factor α and its receptors in relapsing-remitting multiple sclerosis 15
Immunità e flogosi nella malattia di Alzheimer 15
Occurence and clinical relevance of an interleukin-4 gene polymorphism im patients with multiple sclerosis 15
The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymerc mixture, in patients with relapsing-remitting multiple sclerosis 15
Three years of experience: the Italian registry and safety data update 15
Italian frontotemporal dementia network (FTD group-SINDEM): Sharing clinical and diagnostic procedures in Frontotemporal dementia in Italy 15
A polymorphism of the prion protein is moderately associated with age at onset and rate of cognitive impairment in Alzheimer's disease 15
Oligoclonal bands in the cerebrospinal fluid of post-poliomyelitis muscular atrophy ( Reply To Lassman H and to Dalakas M) 15
Identification of peptides specific for cerebrospinal fluid antibodies in multiple sclerosis by using phage libraries 15
Analysis of cerebrospinal fluid IgA and IgG in patients with the Guillain-Barré syndrome | Analisi delle IgA e delle IgG liquorali in pazienti con sindrome di Guillain-Barré 15
Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial 15
Conversion to secondary progressive multiple sclerosis: Patient awareness and needs. Results from an online survey in Italy and Germany 15
Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience 14
Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: A randomised, controlled phase 3 trial 14
The insulin-dependent diabetes mellitus-associated ICA 105 autoantigen in stiff-man syndrome in patients 14
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 14
Effects of donepezil, galantamine and rivastigmine in 938 Italian patients with alzheimers disease: A prospective, observational study 14
Cells producing antibodies specific for myelin basic protein region 70-89 are predominant in cerebrospinal fluid from patients with multiple sclerosis 14
The fate of human peripheral blood lymphocytes after transplantation into SCID mice 14
Restricted heterogeneity of antibody to gp120 and p24 in AIDS 14
Efficacy of vitamin D 3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, doubble-blind, randomized, placebo-controlled trial 14
Immunity and the Stiff-man syndrome: Pathogenetic Problems 14
A new model of HTLV-I neurotropism and lymphoid tumorigenesis in the SCID mouse 14
Signs and symptoms of COVID-19 in patients with multiple sclerosis 14
Interleukin-1 Beta Exon 5 Polymorphism Affects Age of Onset of Alzheimer's Disease 14
Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study 14
Detection of anti-acetylcholine receptor antibody by an ELISA using human receptor from a rhabdomyosarcoma cell line 14
AIDS e Sistema Nervoso | AIDS and the nervous system 14
Real-World Effectiveness of Cladribine for Patients with Multiple Sclerosis: A Sicilian Multicentric Experience (Rewind Study) 14
Totale 1.786
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.212
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.212
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.694 0 0 0 0 0 0 54 151 135 163 530 661
2025/20262.464 354 48 404 561 734 363 0 0 0 0 0 0
Totale 4.158